ArticleFrontiers in oncology2021

Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors.

Jason Fangusaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.